Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Marshall Islands
Marshall Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 62.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Marshall Islands, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Marshall Islands is 62.0%, measured in 2025.
The figure is down 17.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Marshall Islands peaked at 75.0% in 2015 and was at its lowest, 0.0%, in 2008.
That places Marshall Islands 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 24.5% | 0.0% | 49.0% | 2 |
| 2010s | 51.4% | 24.0% | 75.0% | 10 |
| 2020s | 52.3% | 29.0% | 62.0% | 6 |
Countries ranked near Marshall Islands
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 142 Afghanistan 63.0% compare
- 144 Laos 62.0% compare
- 144 Nigeria 62.0% compare
- 147 North Macedonia 60.0% compare
More health data for Marshall Islands
- Heat deaths vs projected death rates 1,179 (2090)
- Un projection of annual infant deaths 2 (2100)
- Age population, age 07, female, interpolated 401 (2025)
- Age population, age 09, male, interpolated 427 (2025)
- Age population, age 09, female, interpolated 412 (2025)
- Age population, age 08, male, interpolated 423 (2025)
- Age population, age 08, female, interpolated 408 (2025)
- Age population, age 07, male, interpolated 419 (2025)
- Age population, age 06, female, interpolated 402 (2025)
- Population, male 18,561 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Marshall Islands?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Marshall Islands was 62.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Marshall Islands?
- The highest recorded value was 75.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Marshall Islands?
- The lowest recorded value was 0.0% in 2008.
- How does Marshall Islands rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Marshall Islands ranks 144th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Marshall Islands?
- Over the last ten years it is down 17.3%. The long-run trend across the full record is rising.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).